Results 351 to 360 of about 3,364,352 (377)

Disadvantages of Neuromuscular Blocking Agents

Veterinary Clinics of North America: Small Animal Practice, 1992
Neuromuscular blocking agents have few indications and significant contraindications or problems associated with their use. The need for controlled ventilation and the difficulties of monitoring anesthetic depth when using neuromuscular blocking agents are overriding factors that mitigate against their routine use.
openaire   +3 more sources

Neuromuscular Blocking Agents in ARDS

New England Journal of Medicine, 2010
In this issue of the Journal, Papazian and colleagues1 present intriguing results of their study examining neuromuscular blockade in patients with severe, early acute respiratory distress syndrome (ARDS). The investigators randomly assigned 340 patients to receive the neuromuscular blocking agent cisatracurium or placebo for a period of 48 hours.
openaire   +3 more sources

Neuromuscular Blockers and Reversal Agents

DeckerMed Anesthesiology, 2019
Neuromuscular blocking drugs, which include depolarizing and nondepolarizing drugs, are used to facilitate intubation and provide skeletal muscle relaxation during surgery and in the intensive care unit. The agents differ in their mechanism, duration of action, side-effect profile, and metabolism.
Jennifer J Yang, Lindsay M Urben, Kristen Flight, Michael J Schontz   +3 more
openaire   +1 more source

Neuromuscular blocking and reversal agents

Anaesthesia & Intensive Care Medicine, 2008
Abstract The neuromuscular junction consists of the motor nerve terminal, the synaptic cleft and post-synaptic nicotinic receptors on the motor end-plate of striated muscle. Neuromuscular blocking drugs are categorized into depolarizing and non-depolarizing agents.
Khorat Farooq, Jennifer M. Hunter
openaire   +2 more sources

Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: A systematic review and meta-analysis of randomized controlled trials.

Journal of clinical anesthesia, 2020
A. Raval, J. Uyei, A. Karabis, L. Bash, S. Brull   +4 more
semanticscholar   +1 more source

Neuromuscular blocking agents

Nursing, 2020
openaire   +3 more sources

Neuromuscular blocking agents

The American Journal of Medicine, 1955
openaire   +3 more sources

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

Anesthesiology, 2016
C. Bulka, Maxim Terekhov, B. Martin, R. Dmochowski, R. Hayes, Jesse M. Ehrenfeld   +5 more
semanticscholar   +1 more source

Neuromuscular Blocking Agents

Veterinary Clinics of North America: Small Animal Practice, 1992
openaire   +3 more sources

Six years without pholcodine; Norwegians are significantly less IgE‐sensitized and clinically more tolerant to neuromuscular blocking agents

Allergy. European Journal of Allergy and Clinical Immunology, 2017
G. D. Pater, E. Florvaag, E. Florvaag, S. G. O. Johansson, S. Johansson, Å. Irgens, M. N. H. Petersen, A. Guttormsen, A. Guttormsen   +8 more
semanticscholar   +1 more source